Journal

High certainty and clinical recommendation are two different things entirely. A high grade can sit next to a treatment that should not be used, and confusing the two is a genuinely...

iatroX's evidence hierarchy for UK point-of-care questions runs from authoritative national guidance through systematic reviews to individual trials, with clinical judgement determ...

EvidenceGrade gives clinicians a real-time letter grade for cited evidence. The idea is sound. Whether a single letter can honestly represent a multi-claim clinical answer is a gen...

Much of the debate about clinical AI concerns diagnosis and autonomous recommendation. A weekly research digest built on public abstracts, with no patient data and no claim to repl...

Some clinical information should be pushed to a doctor before they know they need it. Other information should be pulled the moment a specific question arises. Few single products ...

A UK palliative medicine consultant built a weekly literature digest to solve a problem he and his colleagues actually had. It is a small, well-scoped example of what clinician-led...

MRCGP, ABFM and RACGP-trained doctors carry genuinely strong foundations into CCFP preparation. Canada-specific content, and the SAMP and SOO formats themselves, still require dedi...

USMLE and PLAB preparation build genuinely transferable clinical knowledge, but neither reliably covers the Canadian-specific content the MCCQE actually tests.

Medical AI companies are expanding from narrow, single-purpose tools into fuller vertically integrated systems. Neko's raise is the clearest evidence yet of how far that shift can ...

Heidi's reported Midlands framework is a sign that the NHS AI scribe market is moving from clinician-led pilots to regional infrastructure, and the next contest will not simply be ...

Class IIa certification is meaningful regulatory assurance. It is not proof that Heidi, Tandem or TORTUS produces the best note, and comparing certificates properly requires more t...

A regional AVT deployment is a rare chance to build robust UK evidence, provided success is measured across safety, adoption and patient experience, not just minutes saved.